The information on this site is not intended or implied to be a substitute for professional medical advice, diagnosis or treatment. Content within the patient forum is user-generated and has not been reviewed by medical professionals. Other sections of the Melanoma Research Foundation website include information that has been reviewed by medical professionals as appropriate. All medical decisions should be made in consultation with your doctor or other qualified medical professional.

MCrew

View Profile

Base

Bio

I am a Stage IV metastatic melanoma survivor, cancer free since September 2021,  thanks to Relativity-047 clinical trial. I received the combination of Relatlimab, a LAG-3–blocking antibody, and Nivolumab, a PD-1–blocking antibody during the clinical trial.  I stopped immunotherapy infusions beginning January 2023 because the immunotherapy related adverse effect of Fatigue was becoming debilitating.

Display Name

MCrew

I am

the patient

Initial Diagnosis Month

March

Initial Diagnosis Year

2021

Stage at Diagnosis

Stage 4